Baker Bros. Advisors »

Pfizer shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Pfizer

Tip: Access up to 7 years of quarterly data

All positions including Pfizer held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pfizer by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 35k 28.79

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Mirati Therapeutics
Immunocore Holdings Ads (IMCR)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Invitae Corporation Notes 1.5% 4/1/2028 (Principal)
Abcellera Biologics (ABCL)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Entrada Therapeutics (TRDA)
Ultragenyx Pharmaceutical (RARE)

View all positions for Baker Bros. Advisors

Top funds holding Pfizer

Vanguard Group
Wellington Management Company
Charles Schwab Investment Management
Norges Bank Investment Management
Massachusetts Financial Services
State Farm Mutual Automobile Insurance Company
Bank of America Corporation
Legal & General Group
Amundi
Jpmorgan Chase & Co
Bank of New York Mellon
Dimensional Fund Advisors
Citadel Advisors
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates

View all funds holding Pfizer